Strong first-day trading for iX Biopharma
Shares close trading up 21.7 per cent at S$0.56 after intra-day high of S$0.64
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SPECIALTY pharmaceutical company iX Biopharma made a strong trading debut on the Singapore Exchange Catalist board on Wednesday.
Shares of iX Biopharma, the second healthcare company in less than two months to breathe life into an otherwise moribund initial public offering (IPO) market, kicked off trading at S$0.495, 3.5 Singapore cents or 7.6 per cent above its IPO price of S$0.46.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
